FDA
approval
· 2017-01-06
FDA Approved: DESOXIMETASONE — Original Application (Saptalis Pharmaceuticals, LLC.)
Summary
The FDA approved an original ANDA application from Saptalis Pharmaceuticals for a desoximetasone topical product, a generic corticosteroid for inflammatory skin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DESOXIMETASONE (DESOXIMETASONE)